Loading...
LifeMD, Inc.
LFMD•NASDAQ
HealthcareMedical - Pharmaceuticals
$12.72
$0.64(5.30%)
LifeMD, Inc. (LFMD) Financial Performance & Statements
Review LifeMD, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
39.27%
↑ 39.27%
Operating Income Growth
-11.43%
↓ 11.43%
Net Income Growth
8.32%
↑ 8.32%
Operating Cash Flow Growth
98.56%
↑ 98.56%
Operating Margin
0.04%
↑ 0.04%
Gross Margin
91.97%
↑ 91.97%
Net Profit Margin
-5.21%
↓ 5.21%
ROE
233.13%
↑ 233.13%
ROIC
0.77%
↑ 0.77%
LifeMD, Inc. (LFMD) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for LifeMD, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $64.25M | $40.28M | $50.66M | $44.14M |
| Cost of Revenue | $9.43M | -$8.10M | $7.76M | $6.45M |
| Gross Profit | $54.82M | $48.38M | $42.90M | $37.70M |
| Gross Profit Ratio | $0.85 | $1.20 | $0.85 | $0.85 |
| R&D Expenses | $2.41M | $0.00 | $2.40M | $2.09M |
| SG&A Expenses | $45.76M | $45.54M | $44.90M | $39.48M |
| Operating Expenses | $53.81M | $45.54M | $49.21M | $43.87M |
| Total Costs & Expenses | $63.24M | $37.43M | $56.97M | $50.32M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $558597.00 | $531468.00 | $477678.00 |
| Depreciation & Amortization | $2.55M | $2.56M | $2.29M | $2.10M |
| EBITDA | $3.57M | -$2.13M | -$4.02M | -$4.07M |
| EBITDA Ratio | $0.06 | -$0.05 | -$0.08 | -$0.09 |
| Operating Income | $1.02M | $2.84M | -$6.31M | -$6.17M |
| Operating Income Ratio | $0.02 | $0.07 | -$0.12 | -$0.14 |
| Other Income/Expenses (Net) | -$614074.00 | -$8.09M | -$531468.00 | -$477678.00 |
| Income Before Tax | $404168.00 | -$5.24M | -$6.84M | -$6.65M |
| Income Before Tax Ratio | $0.006 | -$0.13 | -$0.13 | -$0.15 |
| Income Tax Expense | $169477.00 | $232523.00 | $38601.00 | $119437.00 |
| Net Income | -$106272.00 | -$5.91M | -$6.88M | -$6.77M |
| Net Income Ratio | -$0.002 | -$0.15 | -$0.14 | -$0.15 |
| EPS | -$0.003 | -$0.14 | -$0.17 | -$0.17 |
| Diluted EPS | -$0.003 | -$0.14 | -$0.17 | -$0.17 |
| Weighted Avg Shares Outstanding | $42.21M | $42.02M | $41.30M | $39.24M |
| Weighted Avg Shares Outstanding (Diluted) | $42.21M | $42.02M | $41.30M | $39.24M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan